I'm homology-modeling the ubiquitin-bound form of a deubiquitinase for which only the apo form is available as a crystal structure, using a homolog that has a crystal structure with ubiquitin bound. I'm performing energy minimization on the model, but I'm wondering if there are any pitfalls in doing this.

Specifically, would this cause the model to not reflect the likely conformation of the ubiquitin-bound form, for whatever reason? And when I perform energy minimization, would it be advantageous to include ubiquitin (from the homolog's crystal structure) superposed in the active site?

More Lon W. R. Fong's questions See All
Similar questions and discussions